Danish healthcare company Novo Nordisk is on a mission to defeat chronic diseases—but it takes impact seriously in other areas, too. A Triple Bottom Line principle enshrined in the company’s ...

The Danish maker of Ozempic and Wegovy reported a 25 percent increase in sales to $40.6 billion, but said it expected slower growth this year.